SBMT Elects A Scientist-Inventor to Promote Entrepreneurship in Brain Science

Twenty three years ago, working in the very space at Atkinson Morley’s Hospital used by Hounsfield to assemble the world’s first CT scanner – on a hill top in the south London suburb of Wimbledon – I was one of the scientists who conceived of mathematical and engineering steps that led to the Diffusion Anisotropy Imaging patent (US 5,560,360) and so contributed to the birth of...

Read More

NeuroGrafix Statements on GE, University of California Regents, Medtronics and Philips Litigations

The NeuroGrafix patent litigation against The Regents of the University of California and GE was dismissed in November 2012 pursuant to a confidential Settlement Agreement and Mutual Release. Pursuant to that agreement, GE obtained a license for itself and its customers. The NeuroGrafix patent litigation against Medtronic Navigation, Inc. and Medtronic, Inc. was dismissed in February 2013...

Read More

NeuroGrafix Launches National Multi-Litigation in MRI/DTI Patent Dispute

Actions Filed Against the United States/NIH, Johns Hopkins, Brigham/Harvard, Columbia and Cornell November 2, 2012 LOS ANGELES — Today, NeuroGrafix filed two additional lawsuits in Federal District Court in New York accusing Cornell University and Columbia University of patent infringement, following on a New York filing against the Hospital for Special Surgery October 25th. Over the past three...

Read More

NeuroGrafix Statement on US Patent 5,560,360

At this time, NeuroGrafix advises & reminds users of MR Neurography, Diffusion Tensor Imaging (DTI, HARDI, and Q-Ball), or Diffusion Subtraction Neurography that they may be liable for having infringed US Patent 5,560,360 and its foreign equivalents. The issue arises if they are in the US, Japan, Europe, Canada or Australia, and if neither they nor their MRI manufacturer had a license....

Read More

NeuroGrafix Statement on Siemens Litigation

NeuroGrafix makes the following agreed announcement effective today November 22, 2011: “The NeuroGrafix patent litigation against Siemens was dismissed in November 2011 pursuant to a confidential Settlement Agreement and Mutual Release. Pursuant to that agreement, Siemens obtained a license for itself and its customers.”

Read More